Covered recipient · General Payments record
ELIZABETH S GREDELL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$270.31
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.32 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $48.88 | 3 |
| ABBVIE INC. | $34.48 | 2 |
| Novo Nordisk AS | $29.34 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.49 | 1 |
| IBSA Pharma Inc. | $17.91 | 1 |
| GlaxoSmithKline, LLC. | $16.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.05 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832094 | CMS |
| ABBVIE INC. | $17.43 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832096 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.89 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104313286 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.99 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104697046 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.00 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104582172 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $27.49 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086144429 | CMS |
| GlaxoSmithKline, LLC. | $16.22 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116132491 | CMS |
| IBSA Pharma Inc. | $17.91 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142988172 | CMS |
| Novo Nordisk Inc | $15.88 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097741325 | CMS |
| Novo Nordisk Inc | $13.46 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096776517 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.